Hospitals Could Be Better Designed
In an article for The New York Times, Druv Khullar, MD, wrote that hospitals are poorly designed for patients to rest and heal. Hospitals are incredibly expensive to build, but the close quarters, which increase the risk of infections, are not the only design flaw: surfaces could be easier to clean, sinks could be better positioned, and air filters could be of a higher quality. These 3 minor changes could reduce rates of hospital-acquired infections even further. There are additional issues, such as noise, lighting, and even the height of the toilets.
Addicts Continue Taking Opioids During Treatment
Many people undergoing treatment for opioid addiction relapse, and for a long time no one knew why. A new study has found that nearly half of people being treated for opioid addiction fill at least 1 opioid prescription, reported The Washington Post. In addition, people take buprenorphine to treat their opioid addiction for a far shorter time period than experts believe it will take to overcome substance abuse disorder. Physicians are mostly still unaware of what other physicians prescribe, so patients receiving medication-assisted treatment might get an opioid prescription from another doctor.
Medicaid Expansion Divides Republicans
Would a repeal of the Affordable Care Act (ACA) also end Medicaid expansion, thus cutting funding to those states that have expanded the program? According to The Hill, Republicans are divided over how to handle Medicaid through the process of repealing the ACA. Some Republicans want a transition period, while others want to cut the strings quickly. There are 20 Republican senators from states that expanded Medicaid, while 32 represent states that chose not to expand. Some Republican governors, such as John Kasich in Ohio, have been outspoken about keeping expansion.
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
EMBARK Data Show Continued Improvements With DMD Gene Therapy
March 19th 2025Data from the EMBARK trial of delandistrogene moxeparvovec in patients with Duchenne muscular dystrophy (DMD) show that benefits in functional outcomes, gene expression, and muscle imaging persist 2 years after receiving the gene therapy.
Read More